OrbiMed’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,029,300
| Closed | -$47M | – | 130 |
|
|
2023
Q1 | $47M | Hold |
2,029,300
| – | – | 0.92% | 37 |
|
|
2022
Q4 | $53.2M | Hold |
2,029,300
| – | – | 1.02% | 36 |
|
|
2022
Q3 | $39.9K | Buy |
2,029,300
+133,000
| +7% | +$2.62K | 0.74% | 51 |
|
|
2022
Q2 | $33.2K | Buy |
1,896,300
+478,000
| +34% | +$8.36K | 0.6% | 52 |
|
|
2022
Q1 | $23.2M | Hold |
1,418,300
| – | – | 0.38% | 62 |
|
|
2021
Q4 | $23.1M | Sell |
1,418,300
-2,337
| -0.2% | -$38.1K | 0.3% | 80 |
|
|
2021
Q3 | $18.1M | Buy |
1,420,637
+86,836
| +7% | +$1.11M | 0.2% | 102 |
|
|
2021
Q2 | $18.8M | Buy |
1,333,801
+83,800
| +7% | +$1.18M | 0.19% | 101 |
|
|
2021
Q1 | $19.4M | Hold |
1,250,001
| – | – | 0.18% | 99 |
|
|
2020
Q4 | $19.8M | Buy |
+1,250,001
| New | +$19.8M | 0.17% | 102 |
|
|
2016
Q1 | – | Sell |
-12,000
| Closed | -$1.69M | – | 142 |
|
|
2015
Q4 | $1.69M | Sell |
12,000
-201,104
| -94% | -$28.3M | 0.02% | 118 |
|
|
2015
Q3 | $20.6M | Hold |
213,104
| – | – | 0.21% | 70 |
|
|
2015
Q2 | $32.3M | Buy |
+213,104
| New | +$32.3M | 0.27% | 67 |
|